Antiviral Research, Craig R Rayner, Karen Yeo, David Wesche, Lisa Almond, Michael Dodds, Patrick F Smith, Mark Sullivan
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre -including this research content -immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
References
Baraka, Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus, Eur. J. Clin. Pharmacol
Crump, Omura, Ivermectin, 'wonder drug' from Japan: the human use perspective, Proc. Jpn. Acad. Ser. B Phys. Biol. Sci
Guzzo, Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects, J. Clin. Pharmacol
Jans, Kylie, Caly, Druce, Catton et al., The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro, Antiviral Res
Merck, None, Mectizan NDA
Merck, Stromectol USPI
Navarro, Camprubí, Requena-Méndez, Buonfrate, Giorli et al., Safety of high-dose ivermectin: a systematic review and meta-analysis, J. Antimicrob. Chemother
Noël, Lima, Pharmacological aspects and clues for the rationale use of Chloroquine/Hydroxychloroquine facing the therapeutic challenges of COVID-19 pandemic, Lat. Am. J. Clin. Sci. Med. Technol
Pimenta, Silva, Noël, Ivermectin is a nonselective inhibitor of mammalian P-type ATPases, Naunyn-Schmied Arch. Pharmacol
Smit, Ochomo, Waterhouse, Kwambai, Abong'o et al., Pharmacokinetics-pharmacodynamics of high dose ivermectin with Dihydroartemisinin-piperaquine on mosquitocidal activity and QT-prolongation (IVERMAL), Clin. Pharmacol. Ther
Smit, Pharmacokinetics-pharmacodynamics of high-dose ivermectin with dihydroartemisinin-piperaquine on mosquitocidal activity and QT-prolongation (IVERMAL), Clin. Pharmacol. Ther
Tay, Fraser, Chan, Moreland, Rathore et al., Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin, Antivir. Res,
doi:10.1016/j.2013SepYang, Atkinson, Wang, Lee, Bogoyevitch et al., The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer
Yao, In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Clin. Infect. Dis
{ 'indexed': {'date-parts': [[2024, 5, 3]], 'date-time': '2024-05-03T08:27:46Z', 'timestamp': 1714724866712},
'reference-count': 0,
'publisher': 'Elsevier BV',
'license': [ { 'start': { 'date-parts': [[2020, 6, 1]],
'date-time': '2020-06-01T00:00:00Z',
'timestamp': 1590969600000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}],
'content-domain': {'domain': ['elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True},
'published-print': {'date-parts': [[2020, 6]]},
'DOI': '10.1016/j.antiviral.2020.104805',
'type': 'journal-article',
'created': {'date-parts': [[2020, 4, 21]], 'date-time': '2020-04-21T15:26:55Z', 'timestamp': 1587482815000},
'page': '104805',
'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy',
'source': 'Crossref',
'is-referenced-by-count': 87,
'title': 'Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, '
"two letters to the editor and the authors' responses",
'prefix': '10.1016',
'volume': '178',
'author': [ {'given': 'Mike', 'family': 'Bray', 'sequence': 'first', 'affiliation': []},
{'given': 'Craig', 'family': 'Rayner', 'sequence': 'additional', 'affiliation': []},
{'given': 'François', 'family': 'Noël', 'sequence': 'additional', 'affiliation': []},
{'given': 'David', 'family': 'Jans', 'sequence': 'additional', 'affiliation': []},
{'given': 'Kylie', 'family': 'Wagstaff', 'sequence': 'additional', 'affiliation': []}],
'member': '78',
'container-title': 'Antiviral Research',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0166354220302199?httpAccept=text/xml',
'content-type': 'text/xml',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://api.elsevier.com/content/article/PII:S0166354220302199?httpAccept=text/plain',
'content-type': 'text/plain',
'content-version': 'vor',
'intended-application': 'text-mining'}],
'deposited': { 'date-parts': [[2020, 6, 13]],
'date-time': '2020-06-13T00:44:34Z',
'timestamp': 1592009074000},
'score': 1,
'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0166354220302199'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2020, 6]]},
'references-count': 0,
'alternative-id': ['S0166354220302199'],
'URL': 'http://dx.doi.org/10.1016/j.antiviral.2020.104805',
'relation': {},
'ISSN': ['0166-3542'],
'subject': [],
'container-title-short': 'Antiviral Research',
'published': {'date-parts': [[2020, 6]]},
'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'},
{ 'value': 'Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, '
"an FDA warning, two letters to the editor and the authors' responses",
'name': 'articletitle',
'label': 'Article Title'},
{'value': 'Antiviral Research', 'name': 'journaltitle', 'label': 'Journal Title'},
{ 'value': 'https://doi.org/10.1016/j.antiviral.2020.104805',
'name': 'articlelink',
'label': 'CrossRef DOI link to publisher maintained version'},
{'value': 'simple-article', 'name': 'content_type', 'label': 'Content Type'},
{'value': '© 2020 Published by Elsevier B.V.', 'name': 'copyright', 'label': 'Copyright'}],
'article-number': '104805'}
